JSH Co., a Tokyo Stock Exchange Growth-listed operator of disability-employment farms and home medical care services, told shareholders that demand tied to Japan's semiconductor build-out in Kumamoto has outrun its own forecasts by enough to force a rare mid-year upgrade.
The company raised its operating profit forecast for the year to March 2027 by 121.5%, to ¥395mn from an earlier ¥178mn, and lifted its net profit forecast by 375.5%, to ¥192mn from ¥40mn. JSH said the revision came mainly from its regional revitalization business, where orders from semiconductor-related companies clustered around its Kumamoto farm, plus additional orders from existing corporate clients, exceeded what the company had planned for.
What the farms actually do
JSH's regional revitalization business runs farms, branded Cordiare, that employ people with disabilities to grow produce, largely under contract to corporate clients who use the arrangement to meet their own disability-employment obligations. The company had budgeted for a large increase in marketing spending, on advertising and staff, to chase growth in that business. Instead, orders arrived faster than the marketing push could, so JSH pulled back part of that planned spending, a decision it expects to hold at a similar level going forward. The company said it still expects to spend on advertising at roughly the same level rather than cutting it further.
The medium-term math
Alongside the upgrade, JSH disclosed its first medium-term business plan, covering the two years after the current one. Sales are targeted to rise from a forecast ¥6.461bn this year to ¥8.465bn next year and ¥10.658bn by the year to March 2029, while operating profit is targeted to climb from ¥395mn to ¥780mn and then ¥1.321bn over the same stretch.
| Metric | Prior FY26 Forecast | New FY26 Forecast | FY27 Target | FY28 Target |
|---|---|---|---|---|
| Sales | 6,380 | 6,461 | 8,465 | 10,658 |
| Operating profit | 178 | 395 | 780 | 1,321 |
| Net profit | 40 | 192 | 450 | 721 |
The regional revitalization segment itself is only part of that ramp. Its operating profit is now forecast at ¥1.214bn this year, up 23.3% from the prior forecast, with margin rising to 28.3% from an initially planned 23.2%. JSH also flagged that it has adjusted its farm-opening plans, partly to lift productivity per farm, though it said finding suitable sites in the Kanto and Kansai regions has not become harder.
The other half of the business needed fixing first
The upgrade was not one-directional. JSH's home medical care business, built around visiting nursing and support for psychiatric outpatient care, is being pared back. The company said it revised down the number of sites it had targeted for the current and following year, shifting instead toward closing and consolidating multiple locations to get back to profitability sooner. Despite the base cuts, JSH said site counts remain roughly double what they were three years ago, and it still expects the segment's revenue to grow strongly.
What's still open
JSH's plan rests on continued strength in corporate demand for disability-employment placements tied to the Kumamoto cluster, a single regional concentration that the company itself flags as the primary driver of this year's upgrade. The disclosure does not name the semiconductor companies involved or specify contract terms, and JSH's own medium-term targets assume the current order pace holds through the year to March 2029, three fiscal years out. The company's IoT solutions unit, its smallest segment, is still forecast to lose ¥77mn this year despite growth in usage.